Quince Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2018 | $-3.2M | $-3.2M | — | $13.0K |
| Mar 2019 | $-7.2M | $-7.3M | $51.0K | $190.0K |
| Mar 2020 | $-10.8M | $-10.8M | $5.0K | $2.0M |
| Mar 2021 | $-13.6M | $-13.6M | $37.0K | $7.0M |
| Mar 2022 | $-16.1M | $-16.1M | $5.0K | $9.2M |
| Mar 2023 | $-3.6M | $-3.7M | $136.0K | $1.5M |
| Mar 2024 | $-8.4M | $-8.4M | $39.0K | $1.3M |
| Mar 2025 | $-9.6M | $-9.7M | $148.0K | $1.4M |
| Mar 2026 | $-7.6M | $-7.6M | $0 | $1.3M |